SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

Credit Suisse Maintains Outperform on Globus Medical, Lowers Price Target to $59

Credit Suisse maintains Globus Medical (NYSE:GMED) with a Outperform and lowers the price target from $67 to $59.

Benzinga · 03/06/2020 15:36

Credit Suisse maintains Globus Medical (NYSE:GMED) with a Outperform and lowers the price target from $67 to $59.